Variant report
Variant | esv3353295 |
---|---|
Chromosome Location | chr4:127994396-128017617 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:7)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr4:128007689-128008011 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr4:128000425-128000755 | HepG2 | liver: | n/a | chr4:128000568-128000577 chr4:128000568-128000577 chr4:128000487-128000500 chr4:128000566-128000577 chr4:128000568-128000579 chr4:128000568-128000577 chr4:128000568-128000577 |
3 | CEBPB | chr4:128000426-128000753 | IMR90 | lung: | n/a | chr4:128000568-128000577 chr4:128000568-128000577 chr4:128000487-128000500 chr4:128000566-128000577 chr4:128000568-128000579 chr4:128000568-128000577 chr4:128000568-128000577 |
4 | CEBPB | chr4:128000397-128000737 | K562 | blood: | n/a | chr4:128000568-128000577 chr4:128000568-128000577 chr4:128000487-128000500 chr4:128000566-128000577 chr4:128000568-128000579 chr4:128000568-128000577 chr4:128000568-128000577 |
5 | CEBPB | chr4:128000438-128000707 | ECC-1 | luminal epithelium: | n/a | chr4:128000568-128000577 chr4:128000568-128000577 chr4:128000487-128000500 chr4:128000566-128000577 chr4:128000568-128000579 chr4:128000568-128000577 chr4:128000568-128000577 |
6 | CEBPB | chr4:128000473-128000732 | A549 | lung: | n/a | chr4:128000568-128000577 chr4:128000568-128000577 chr4:128000487-128000500 chr4:128000566-128000577 chr4:128000568-128000579 chr4:128000568-128000577 chr4:128000568-128000577 |
7 | CEBPB | chr4:127994767-127994988 | HepG2 | liver: | n/a | chr4:127994862-127994871 chr4:127994862-127994873 chr4:127994860-127994873 |
8 | CEBPB | chr4:128015624-128015727 | A549 | lung: | n/a | n/a |
9 | E2F4 | chr4:128002351-128002446 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | EP300 | chr4:128016773-128016880 | GM12878 | blood: | n/a | n/a |
11 | FOS | chr4:128005965-128005999 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr4:128005994-128006005 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOS | chr4:128005914-128006063 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | FOXA2 | chr4:127998090-127998418 | A549 | lung: | n/a | n/a |
15 | KAP1 | chr4:128007661-128008106 | HEK293 | kidney: | n/a | n/a |
16 | MAFF | chr4:127995556-127995681 | K562 | blood: | n/a | n/a |
17 | MAFK | chr4:127995449-127995765 | HepG2 | liver: | n/a | chr4:127995612-127995623 |
18 | MAFK | chr4:127995582-127995709 | K562 | blood: | n/a | chr4:127995612-127995623 |
19 | MAFK | chr4:127995452-127995764 | IMR90 | lung: | n/a | chr4:127995612-127995623 |
20 | MAZ | chr4:128002856-128002886 | HepG2 | liver: | n/a | n/a |
21 | POLR2A | chr4:127995934-127996002 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | POLR2A | chr4:127995349-127995751 | SK-N-MC | brain: | n/a | n/a |
23 | RCOR1 | chr4:127994162-127994463 | K562 | blood: | n/a | n/a |
24 | REST | chr4:128000625-128000940 | ECC-1 | luminal epithelium: | n/a | chr4:128000746-128000755 |
25 | REST | chr4:128000509-128000892 | PFSK-1 | brain: | n/a | chr4:128000746-128000755 |
26 | RFX5 | chr4:127995772-127995798 | K562 | blood: | n/a | n/a |
27 | SETDB1 | chr4:128007655-128008139 | U2OS | brain: | n/a | n/a |
28 | SMC3 | chr4:128000520-128000643 | HepG2 | liver: | n/a | n/a |
29 | STAT3 | chr4:128009246-128009407 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | STAT3 | chr4:128001654-128001830 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | ZNF143 | chr4:128007720-128007931 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:7 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MFSD8-4 | chr4:128016259-128016504 | XLOC_004067 |
2 | lnc-MFSD8-4 | chr4:128015586-128015631 | XLOC_004067 |
3 | lnc-MFSD8-4 | chr4:128016259-128016421 | XLOC_004067 |
4 | lnc-MFSD8-5 | chr4:127998890-127998917 | XLOC_004066 |
5 | lnc-MFSD8-4 | chr4:128017487-128017878 | XLOC_004067 |
6 | lnc-MFSD8-4 | chr4:128015620-128015631 | XLOC_004067 |
7 | lnc-MFSD8-5 | chr4:127994931-127995045 | XLOC_004066 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250945 | TF binding region |
PIK3CA | miRNA target sites |
ITGA5 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13122080 | chr4:127994423-127994424 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs150195596 | chr4:127994559-127994560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs180727380 | chr4:127994560-127994561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571094462 | chr4:127994564-127994565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372586574 | chr4:127994565-127994566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531358044 | chr4:128000417-128000418 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs17291337 | chr4:128000462-128000463 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs17012074 | chr4:128000472-128000473 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs138015431 | chr4:128000538-128000539 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs72925316 | chr4:128000558-128000559 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs551284660 | chr4:128000596-128000597 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs569421452 | chr4:128000611-128000612 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs188890881 | chr4:128000655-128000656 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs532534427 | chr4:128000705-128000706 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs575628692 | chr4:128000723-128000724 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs113602990 | chr4:128000772-128000773 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs192280545 | chr4:128000786-128000787 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs555160922 | chr4:128000862-128000863 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs371279352 | chr4:128001204-128001205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs59922433 | chr4:128001245-128001246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373316187 | chr4:128001287-128001288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542414097 | chr4:128001301-128001302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115687059 | chr4:128001334-128001335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563533410 | chr4:128001339-128001340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539972192 | chr4:128001350-128001351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75574075 | chr4:128001357-128001358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145625072 | chr4:128001369-128001370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550271963 | chr4:128001374-128001375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147725464 | chr4:128001388-128001389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs6821701 | chr4:128001392-128001393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1552089 | chr4:128001445-128001446 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs35943375 | chr4:128001495-128001496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111504627 | chr4:128001498-128001499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184615206 | chr4:128001510-128001511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567111469 | chr4:128001573-128001574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs72925318 | chr4:128001584-128001585 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs139859838 | chr4:128001588-128001589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570833210 | chr4:128001629-128001630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113993632 | chr4:128001630-128001631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538256325 | chr4:128001646-128001647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556235579 | chr4:128001680-128001681 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs528542631 | chr4:128001690-128001691 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs72925319 | chr4:128001702-128001703 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs576469513 | chr4:128001721-128001722 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs548394967 | chr4:128001751-128001752 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs371910218 | chr4:128001789-128001790 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs17212899 | chr4:128001835-128001836 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs572727709 | chr4:128001924-128001925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540024822 | chr4:128001936-128001937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565007459 | chr4:128001968-128001969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:127994200-127994600 | Enhancers | K562 | blood |
2 | chr4:128001200-128001800 | Enhancers | Fetal Lung | lung |
3 | chr4:128001400-128002600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr4:128001800-128004200 | Weak transcription | Fetal Lung | lung |
5 | chr4:128002600-128003400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr4:128003400-128004600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr4:128004200-128004800 | Enhancers | Fetal Lung | lung |
8 | chr4:128004800-128007600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr4:128007400-128007800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr4:128007600-128008000 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr4:128007600-128008200 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
12 | chr4:128009000-128009200 | ZNF genes & repeats | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr4:128009200-128011000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
14 | chr4:128009800-128010200 | Enhancers | Lung | lung |